Our Bond, Inc.
Filed Jul 17, 2026.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Jul 17, 2026
Contents
Capitalization
The following table sets forth our capitalization as of March 31, 2026.
This table should be read in conjunction with, and is qualified in its entirety by reference to, our financial statements and related notes, and the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” appearing elsewhere in this prospectus. In addition, the following capitalization table presents our capitalization as of March 31, 2025 on (a) an actual basis and (b) a pro forma basis to give effect to our issuance of 366,941 shares of Series G Preferred Stock in exchange for outstanding promissory notes in the total amount of $3,302,457,58 as if such transaction had occurred as of March 31, 2026.
| As of March 31, 2026 | As of March 31, 2026 | |
|---|---|---|
| Actual | Proforma | |
| (in thousands, except per share numbers) | ||
| Debt: | ||
| Loan | 7,437 | 7,437 |
| Convertible Revolving Promissory Note (Related Party) | 212 | 212 |
| Total indebtedness | 7,649 | 7,649 |
| Mezzanine Equity | ||
| Series C convertible Preferred Stock | 2,746 | 2,746 |
| Series D convertible Preferred Stock | 1,989 | 1,989 |
| Series G convertible Preferred Stock | - | 3,669 |
| Stockholders’ deficit: | ||
| Preferred Stock, $0.0001 par value per share; 148,438,108 shares authorized; 14,829,942 shares issued and outstanding | 2 | 2 |
| Common Stock, $0.0001 par value per share; 200,000,000 shares authorized; 21,074,608 shares issued and outstanding | 2 | 2 |
| Additional paid-in capital | 131,196 | 130,829 |
| Accumulated other comprehensive income | (97) | (97) |
| Accumulated deficit | (146,076) | (146,076) |
| Total stockholders’ deficit | (14,973) | (15,340) |
| Total Capitalization | (2,589) | 713 |
The number of shares of our Common Stock reflected in our actual information set forth in the table above excludes:
| ● | 9,330,085 shares of Common Stock issuable upon exercise of warrants outstanding as of March 31, 2026; and |
| ● | 15,353,210 shares of Common Stock reserved for issuance under our Amended and Restated 2017 Equity Plan, as amended from time to time (the “Amended and Restated Equity Plan”). |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.